1
Novel 3D Myeloma Organoid to Study Disease Biology and Chemosensitivity
Condition(s):Multiple MyelomaLast Updated:July 24, 2020Recruiting
Neoplasms, Plasma Cell: 3226 Clinical Trials, Page 1 of 323
Hide Studies Not Open or Pending
2
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:April 5, 2018Completed
3
Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:December 30, 2019Not yet recruiting
4
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 16, 2020Recruiting
5
Assessing Glutamine Metabolism in MGUS and Myeloma
Condition(s):Myeloma; MGUSLast Updated:June 5, 2020Recruiting
6
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
Condition(s):Multiple MyelomaLast Updated:August 16, 2018Active, not recruiting
7
CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma
Condition(s):Relapsed/Refractory Multiple Myeloma(MM)Last Updated:August 16, 2019Recruiting
8
Role of Osteocytes in Myeloma Bone Disease
Condition(s):Multiple MyelomaLast Updated:October 18, 2018Recruiting
9
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Condition(s):Multiple MyelomaLast Updated:August 2, 2019Recruiting
10
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Condition(s):Multiple MyelomaLast Updated:January 15, 2019Completed